TRLS-06. A PHASE 1, SAFETY AND DOSE ESCALATION STUDY OF BXQ-350 IN COMBINATION WITH RADIATION IN PEDIATRIC PATIENTS WITH DIFFUSE MIDLINE GLIOMA OR DIFFUSE INTRINSIC PONTINE GLIOMA

This trial (NCT04771897) is currently enrolling at 3 US sites; as of January 2023, a total of 8 patients have been enrolled. Enrollment of cohort 1 (2.4 mg/kg and 54 Gy) and cohort 2 (3.2 mg/kg and 54 Gy) are completed. Enrollment in the expansion cohort is on-going. To date, no dose-limiting toxici...

Descripción completa

Detalles Bibliográficos
Autores principales: Dorris, Kathleen, Fouladi, Maryam, Hummel, Trent, Raskin, Scott, III, Richard Curry, Purvis, Joseph, Gazda, Michael, Tapolsky, Gilles, Takigiku, Ray
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Final Category: Translational Therapeutics/Clinical Trials - TRLS
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10259979/
http://dx.doi.org/10.1093/neuonc/noad073.309

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10259979/
http://dx.doi.org/10.1093/neuonc/noad073.309

Ejemplares similares